Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Biopreservation Market by Type (Biopreservation Media, Biospecimen Equipment, Freezers, Cryogenic Storage Systems, Thawing Equipment, Refrigerators), by Biospecimen (Stem Cells, Organs, Human Tissue Samples, Other Biospecimens), by Application (Research Applications, Therapeutic Applications, Clinical Trials, Other Applications) and by End User (Hospitals, Gene Banks, Biobanks, Other End Users): Global Opportunity Analysis and Industry Forecast, 2023-2032

A09548

Pages: NA

Charts: NA

Tables: NA

The biopreservation market is expected to grow in the upcoming years due to increase in the chronic diseases such as diabetes, cardiac and renal diseases. Increase in the healthcare expenditure also contributing to the growth of the biopreservation market.

Biopreservation is a process which is used in preserving of biospecimens such as plasma, purified DNA and saliva. By usage of this technique the shelf life, purity and safety of the biospecimens can be increased. Biopreservation is used to store cells, tissues and organs with the help of cryopreservation. The technique is also used for food safety nowadays. Equipment used for biopreservation are refrigerators, liquid nitrogen, laboratory information management systems and media. Biobanking is a kind of biopreservation which is used in the field of genomics, medical research and also for personalized medicines.

COVID-19 scenario analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future. Considering these factors, COVID -19 is expected to have significant impact on Biopreservation Market.

Top Impacting factors:

  • Factors such as rise in expenditure for health and advancements made in the biopreservation facilities are fueling the growth of the biopreservation market.
  • Government initiatives for funding R&D activities in biopreservation has resulted in the advancements for biopresevation market.
  • Advancements made in the biopreservation techniques such as next generation cryopreservation, designing and integration with nanoscale technologies are expected to rise the biopreservation market in future.
  • Increase in awareness about the biopreservation has resulted in demand for preservation of human sperms and eggs, new born stem cells. These techniques can be useful for treatment of diseases like autism and cancer.
  • Restrain factors like high cost associated with preservation and tissue injury during the process are hampering the growth of biopreservation market.

New Product Launch / News:

  • In February 2018, BioLife Solutions announced OEM Agreement with MilliporeSigma. OEM agreement is to supply its CryoStor cell freeze media and HypoThermosol cell storage and shipping media under private label to MilliporeSigma.
  • In July 2017, Cesca Therapeutics Inc., market leader of automated cell processing and point-of-care, autologous cell-based therapies, announced that they acquired SynGen Inc., which is a technology company active in the cellular processing field.

Key benefits of the report:

  • This study presents the analytical depiction of the Global Biopreservation Market along with the current trends and future estimations to determine the investments.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Biopreservation Market share.
  • The current market is quantitatively analyzed to highlight the Biopreservation Market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed Biopreservation Market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Biopreservation Market Report:

  • What are the leading market players active in Biopreservation Market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?
  • What Segments and region will drive the market growth & why?

Key Market Segments

  • By Type
    • Biopreservation Media
      • Nutrient Media
      • Sera
      • Growth Factors and Supplements
    • Biospecimen Equipment
      • Temperature Control Systems
    • Freezers
    • Cryogenic Storage Systems
    • Thawing Equipment
    • Refrigerators
      • Accessories
      • Alarms and Monitoring systems
      • Incubators
      • Centrifuges
      • Other Equipment
  • By Biospecimen
    • Stem Cells
    • Organs
    • Human Tissue Samples
    • Other Biospecimens
  • By Application
    • Research Applications
    • Therapeutic Applications
    • Clinical Trials
    • Other Applications
  • By End User
    • Hospitals
    • Gene Banks
    • Biobanks
    • Other End Users
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Biolife Solutions
  • Avantor, Inc.
  • Core Dynamics
  • VWR Corporation
  • Princeton Cryotech
  • Custom Biogenic Systems
  • Sigma-Aldrich Corporation
  • Cesca Therapeutics
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: BIOPRESERVATION MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Biopreservation Media

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

      • 4.2.4. Nutrient Media

        • 4.2.4.1. Market Size and Forecast
      • 4.2.4. Sera

        • 4.2.4.1. Market Size and Forecast
      • 4.2.4. Growth Factors and Supplements

        • 4.2.4.1. Market Size and Forecast
    • 4.3. Biospecimen Equipment

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

      • 4.3.4. Temperature Control Systems

        • 4.3.4.1. Market Size and Forecast
    • 4.4. Freezers

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Cryogenic Storage Systems

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Thawing Equipment

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. Refrigerators

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

      • 4.7.4. Accessories

        • 4.7.4.1. Market Size and Forecast
      • 4.7.4. Alarms and Monitoring systems

        • 4.7.4.1. Market Size and Forecast
      • 4.7.4. Incubators

        • 4.7.4.1. Market Size and Forecast
      • 4.7.4. Centrifuges

        • 4.7.4.1. Market Size and Forecast
      • 4.7.4. Other Equipment

        • 4.7.4.1. Market Size and Forecast
  • CHAPTER 5: BIOPRESERVATION MARKET, BY BIOSPECIMEN

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Biospecimen

    • 5.2. Stem Cells

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Organs

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Human Tissue Samples

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Other Biospecimens

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: BIOPRESERVATION MARKET, BY APPLICATION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Application

    • 6.2. Research Applications

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Therapeutic Applications

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Clinical Trials

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Other Applications

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

  • CHAPTER 7: BIOPRESERVATION MARKET, BY END USER

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End User

    • 7.2. Hospitals

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Gene Banks

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Biobanks

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

    • 7.5. Other End Users

      • 7.5.1. Key Market Trends, Growth Factors and Opportunities

      • 7.5.2. Market Size and Forecast, By Region

      • 7.5.3. Market Share Analysis, By Country

  • CHAPTER 8: BIOPRESERVATION MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Type

      • 8.2.3. Market Size and Forecast, By Biospecimen

      • 8.2.4. Market Size and Forecast, By Application

      • 8.2.5. Market Size and Forecast, By End User

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Biopreservation Market

        • 8.2.7.1. Market Size and Forecast, By Type
        • 8.2.7.2. Market Size and Forecast, By Biospecimen
        • 8.2.7.3. Market Size and Forecast, By Application
        • 8.2.7.4. Market Size and Forecast, By End User
      • 8.2.8. Canada Biopreservation Market

        • 8.2.8.1. Market Size and Forecast, By Type
        • 8.2.8.2. Market Size and Forecast, By Biospecimen
        • 8.2.8.3. Market Size and Forecast, By Application
        • 8.2.8.4. Market Size and Forecast, By End User
      • 8.2.9. Mexico Biopreservation Market

        • 8.2.9.1. Market Size and Forecast, By Type
        • 8.2.9.2. Market Size and Forecast, By Biospecimen
        • 8.2.9.3. Market Size and Forecast, By Application
        • 8.2.9.4. Market Size and Forecast, By End User
    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Type

      • 8.3.3. Market Size and Forecast, By Biospecimen

      • 8.3.4. Market Size and Forecast, By Application

      • 8.3.5. Market Size and Forecast, By End User

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Biopreservation Market

        • 8.3.7.1. Market Size and Forecast, By Type
        • 8.3.7.2. Market Size and Forecast, By Biospecimen
        • 8.3.7.3. Market Size and Forecast, By Application
        • 8.3.7.4. Market Size and Forecast, By End User
      • 8.3.8. Germany Biopreservation Market

        • 8.3.8.1. Market Size and Forecast, By Type
        • 8.3.8.2. Market Size and Forecast, By Biospecimen
        • 8.3.8.3. Market Size and Forecast, By Application
        • 8.3.8.4. Market Size and Forecast, By End User
      • 8.3.9. Italy Biopreservation Market

        • 8.3.9.1. Market Size and Forecast, By Type
        • 8.3.9.2. Market Size and Forecast, By Biospecimen
        • 8.3.9.3. Market Size and Forecast, By Application
        • 8.3.9.4. Market Size and Forecast, By End User
      • 8.3.10. Spain Biopreservation Market

        • 8.3.10.1. Market Size and Forecast, By Type
        • 8.3.10.2. Market Size and Forecast, By Biospecimen
        • 8.3.10.3. Market Size and Forecast, By Application
        • 8.3.10.4. Market Size and Forecast, By End User
      • 8.3.11. UK Biopreservation Market

        • 8.3.11.1. Market Size and Forecast, By Type
        • 8.3.11.2. Market Size and Forecast, By Biospecimen
        • 8.3.11.3. Market Size and Forecast, By Application
        • 8.3.11.4. Market Size and Forecast, By End User
      • 8.3.12. Russia Biopreservation Market

        • 8.3.12.1. Market Size and Forecast, By Type
        • 8.3.12.2. Market Size and Forecast, By Biospecimen
        • 8.3.12.3. Market Size and Forecast, By Application
        • 8.3.12.4. Market Size and Forecast, By End User
      • 8.3.13. Rest Of Europe Biopreservation Market

        • 8.3.13.1. Market Size and Forecast, By Type
        • 8.3.13.2. Market Size and Forecast, By Biospecimen
        • 8.3.13.3. Market Size and Forecast, By Application
        • 8.3.13.4. Market Size and Forecast, By End User
    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Type

      • 8.4.3. Market Size and Forecast, By Biospecimen

      • 8.4.4. Market Size and Forecast, By Application

      • 8.4.5. Market Size and Forecast, By End User

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Biopreservation Market

        • 8.4.7.1. Market Size and Forecast, By Type
        • 8.4.7.2. Market Size and Forecast, By Biospecimen
        • 8.4.7.3. Market Size and Forecast, By Application
        • 8.4.7.4. Market Size and Forecast, By End User
      • 8.4.8. Japan Biopreservation Market

        • 8.4.8.1. Market Size and Forecast, By Type
        • 8.4.8.2. Market Size and Forecast, By Biospecimen
        • 8.4.8.3. Market Size and Forecast, By Application
        • 8.4.8.4. Market Size and Forecast, By End User
      • 8.4.9. India Biopreservation Market

        • 8.4.9.1. Market Size and Forecast, By Type
        • 8.4.9.2. Market Size and Forecast, By Biospecimen
        • 8.4.9.3. Market Size and Forecast, By Application
        • 8.4.9.4. Market Size and Forecast, By End User
      • 8.4.10. South Korea Biopreservation Market

        • 8.4.10.1. Market Size and Forecast, By Type
        • 8.4.10.2. Market Size and Forecast, By Biospecimen
        • 8.4.10.3. Market Size and Forecast, By Application
        • 8.4.10.4. Market Size and Forecast, By End User
      • 8.4.11. Australia Biopreservation Market

        • 8.4.11.1. Market Size and Forecast, By Type
        • 8.4.11.2. Market Size and Forecast, By Biospecimen
        • 8.4.11.3. Market Size and Forecast, By Application
        • 8.4.11.4. Market Size and Forecast, By End User
      • 8.4.12. Thailand Biopreservation Market

        • 8.4.12.1. Market Size and Forecast, By Type
        • 8.4.12.2. Market Size and Forecast, By Biospecimen
        • 8.4.12.3. Market Size and Forecast, By Application
        • 8.4.12.4. Market Size and Forecast, By End User
      • 8.4.13. Malaysia Biopreservation Market

        • 8.4.13.1. Market Size and Forecast, By Type
        • 8.4.13.2. Market Size and Forecast, By Biospecimen
        • 8.4.13.3. Market Size and Forecast, By Application
        • 8.4.13.4. Market Size and Forecast, By End User
      • 8.4.14. Indonesia Biopreservation Market

        • 8.4.14.1. Market Size and Forecast, By Type
        • 8.4.14.2. Market Size and Forecast, By Biospecimen
        • 8.4.14.3. Market Size and Forecast, By Application
        • 8.4.14.4. Market Size and Forecast, By End User
      • 8.4.15. Rest of Asia Pacific Biopreservation Market

        • 8.4.15.1. Market Size and Forecast, By Type
        • 8.4.15.2. Market Size and Forecast, By Biospecimen
        • 8.4.15.3. Market Size and Forecast, By Application
        • 8.4.15.4. Market Size and Forecast, By End User
    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Type

      • 8.5.3. Market Size and Forecast, By Biospecimen

      • 8.5.4. Market Size and Forecast, By Application

      • 8.5.5. Market Size and Forecast, By End User

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Biopreservation Market

        • 8.5.7.1. Market Size and Forecast, By Type
        • 8.5.7.2. Market Size and Forecast, By Biospecimen
        • 8.5.7.3. Market Size and Forecast, By Application
        • 8.5.7.4. Market Size and Forecast, By End User
      • 8.5.8. South Africa Biopreservation Market

        • 8.5.8.1. Market Size and Forecast, By Type
        • 8.5.8.2. Market Size and Forecast, By Biospecimen
        • 8.5.8.3. Market Size and Forecast, By Application
        • 8.5.8.4. Market Size and Forecast, By End User
      • 8.5.9. Saudi Arabia Biopreservation Market

        • 8.5.9.1. Market Size and Forecast, By Type
        • 8.5.9.2. Market Size and Forecast, By Biospecimen
        • 8.5.9.3. Market Size and Forecast, By Application
        • 8.5.9.4. Market Size and Forecast, By End User
      • 8.5.10. UAE Biopreservation Market

        • 8.5.10.1. Market Size and Forecast, By Type
        • 8.5.10.2. Market Size and Forecast, By Biospecimen
        • 8.5.10.3. Market Size and Forecast, By Application
        • 8.5.10.4. Market Size and Forecast, By End User
      • 8.5.11. Argentina Biopreservation Market

        • 8.5.11.1. Market Size and Forecast, By Type
        • 8.5.11.2. Market Size and Forecast, By Biospecimen
        • 8.5.11.3. Market Size and Forecast, By Application
        • 8.5.11.4. Market Size and Forecast, By End User
      • 8.5.12. Rest of LAMEA Biopreservation Market

        • 8.5.12.1. Market Size and Forecast, By Type
        • 8.5.12.2. Market Size and Forecast, By Biospecimen
        • 8.5.12.3. Market Size and Forecast, By Application
        • 8.5.12.4. Market Size and Forecast, By End User
  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning, 2024

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Sigma-Aldrich Corporation

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. Thermo Fisher Scientific Inc.

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. Biolife Solutions

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. Cesca Therapeutics

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. VWR Corporation

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Custom Biogenic Systems

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. Core Dynamics

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Princeton Cryotech

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Merck KGaA

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. Avantor, Inc.

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL BIOPRESERVATION MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL BIOPRESERVATION MARKET FOR BIOPRESERVATION MEDIA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL BIOPRESERVATION MARKET FOR BIOSPECIMEN EQUIPMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL BIOPRESERVATION MARKET FOR FREEZERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL BIOPRESERVATION MARKET FOR CRYOGENIC STORAGE SYSTEMS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL BIOPRESERVATION MARKET FOR THAWING EQUIPMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL BIOPRESERVATION MARKET FOR REFRIGERATORS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL BIOPRESERVATION MARKET FOR STEM CELLS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL BIOPRESERVATION MARKET FOR ORGANS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL BIOPRESERVATION MARKET FOR HUMAN TISSUE SAMPLES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL BIOPRESERVATION MARKET FOR OTHER BIOSPECIMENS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL BIOPRESERVATION MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL BIOPRESERVATION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL BIOPRESERVATION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL BIOPRESERVATION MARKET FOR CLINICAL TRIALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. GLOBAL BIOPRESERVATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. GLOBAL BIOPRESERVATION MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 19. GLOBAL BIOPRESERVATION MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. GLOBAL BIOPRESERVATION MARKET FOR GENE BANKS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 21. GLOBAL BIOPRESERVATION MARKET FOR BIOBANKS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 22. GLOBAL BIOPRESERVATION MARKET FOR OTHER END USERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 23. GLOBAL BIOPRESERVATION MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 24. NORTH AMERICA BIOPRESERVATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 25. NORTH AMERICA BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 26. NORTH AMERICA BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 27. NORTH AMERICA BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 28. NORTH AMERICA BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 29. U.S. BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 30. U.S. BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 31. U.S. BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 32. U.S. BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 33. CANADA BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 34. CANADA BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 35. CANADA BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 36. CANADA BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 37. MEXICO BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 38. MEXICO BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 39. MEXICO BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 40. MEXICO BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 41. EUROPE BIOPRESERVATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 42. EUROPE BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 43. EUROPE BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 44. EUROPE BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 45. EUROPE BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 46. FRANCE BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 47. FRANCE BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 48. FRANCE BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 49. FRANCE BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 50. GERMANY BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 51. GERMANY BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 52. GERMANY BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 53. GERMANY BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 54. ITALY BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 55. ITALY BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 56. ITALY BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 57. ITALY BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 58. SPAIN BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 59. SPAIN BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 60. SPAIN BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 61. SPAIN BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 62. UK BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 63. UK BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 64. UK BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 65. UK BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 66. RUSSIA BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 67. RUSSIA BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 68. RUSSIA BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 69. RUSSIA BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 70. REST OF EUROPE BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 71. REST OF EUROPE BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 72. REST OF EUROPE BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 73. REST OF EUROPE BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 74. ASIA-PACIFIC BIOPRESERVATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 75. ASIA-PACIFIC BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 76. ASIA-PACIFIC BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 77. ASIA-PACIFIC BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 78. ASIA-PACIFIC BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 79. CHINA BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 80. CHINA BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 81. CHINA BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 82. CHINA BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 83. JAPAN BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 84. JAPAN BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 85. JAPAN BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 86. JAPAN BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 87. INDIA BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 88. INDIA BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 89. INDIA BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 90. INDIA BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 91. SOUTH KOREA BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 92. SOUTH KOREA BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 93. SOUTH KOREA BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 94. SOUTH KOREA BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 95. AUSTRALIA BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 96. AUSTRALIA BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 97. AUSTRALIA BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 98. AUSTRALIA BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 99. THAILAND BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 100. THAILAND BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 101. THAILAND BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 102. THAILAND BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 103. MALAYSIA BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 104. MALAYSIA BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 105. MALAYSIA BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 106. MALAYSIA BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 107. INDONESIA BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 108. INDONESIA BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 109. INDONESIA BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 110. INDONESIA BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 111. REST OF ASIA PACIFIC BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 112. REST OF ASIA PACIFIC BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 113. REST OF ASIA PACIFIC BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 114. REST OF ASIA PACIFIC BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 115. LAMEA BIOPRESERVATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 116. LAMEA BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 117. LAMEA BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 118. LAMEA BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 119. LAMEA BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 120. BRAZIL BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 121. BRAZIL BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 122. BRAZIL BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 123. BRAZIL BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 124. SOUTH AFRICA BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 125. SOUTH AFRICA BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 126. SOUTH AFRICA BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 127. SOUTH AFRICA BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 128. SAUDI ARABIA BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 129. SAUDI ARABIA BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 130. SAUDI ARABIA BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 131. SAUDI ARABIA BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 132. UAE BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 133. UAE BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 134. UAE BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 135. UAE BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 136. ARGENTINA BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 137. ARGENTINA BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 138. ARGENTINA BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 139. ARGENTINA BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 140. REST OF LAMEA BIOPRESERVATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 141. REST OF LAMEA BIOPRESERVATION, BY BIOSPECIMEN, 2025-2033 ($MILLION)
  • TABLE 142. REST OF LAMEA BIOPRESERVATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 143. REST OF LAMEA BIOPRESERVATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 144. SIGMA-ALDRICH CORPORATION: KEY EXECUTIVES
  • TABLE 145. SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT
  • TABLE 146. SIGMA-ALDRICH CORPORATION: OPERATING SEGMENTS
  • TABLE 147. SIGMA-ALDRICH CORPORATION: PRODUCT PORTFOLIO
  • TABLE 148. SIGMA-ALDRICH CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 150. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 151. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 152. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 153. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 154. BIOLIFE SOLUTIONS: KEY EXECUTIVES
  • TABLE 155. BIOLIFE SOLUTIONS: COMPANY SNAPSHOT
  • TABLE 156. BIOLIFE SOLUTIONS: OPERATING SEGMENTS
  • TABLE 157. BIOLIFE SOLUTIONS: PRODUCT PORTFOLIO
  • TABLE 158. BIOLIFE SOLUTIONS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 159. CESCA THERAPEUTICS: KEY EXECUTIVES
  • TABLE 160. CESCA THERAPEUTICS: COMPANY SNAPSHOT
  • TABLE 161. CESCA THERAPEUTICS: OPERATING SEGMENTS
  • TABLE 162. CESCA THERAPEUTICS: PRODUCT PORTFOLIO
  • TABLE 163. CESCA THERAPEUTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 164. VWR CORPORATION: KEY EXECUTIVES
  • TABLE 165. VWR CORPORATION: COMPANY SNAPSHOT
  • TABLE 166. VWR CORPORATION: OPERATING SEGMENTS
  • TABLE 167. VWR CORPORATION: PRODUCT PORTFOLIO
  • TABLE 168. VWR CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 169. CUSTOM BIOGENIC SYSTEMS: KEY EXECUTIVES
  • TABLE 170. CUSTOM BIOGENIC SYSTEMS: COMPANY SNAPSHOT
  • TABLE 171. CUSTOM BIOGENIC SYSTEMS: OPERATING SEGMENTS
  • TABLE 172. CUSTOM BIOGENIC SYSTEMS: PRODUCT PORTFOLIO
  • TABLE 173. CUSTOM BIOGENIC SYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 174. CORE DYNAMICS: KEY EXECUTIVES
  • TABLE 175. CORE DYNAMICS: COMPANY SNAPSHOT
  • TABLE 176. CORE DYNAMICS: OPERATING SEGMENTS
  • TABLE 177. CORE DYNAMICS: PRODUCT PORTFOLIO
  • TABLE 178. CORE DYNAMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 179. PRINCETON CRYOTECH: KEY EXECUTIVES
  • TABLE 180. PRINCETON CRYOTECH: COMPANY SNAPSHOT
  • TABLE 181. PRINCETON CRYOTECH: OPERATING SEGMENTS
  • TABLE 182. PRINCETON CRYOTECH: PRODUCT PORTFOLIO
  • TABLE 183. PRINCETON CRYOTECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 184. MERCK KGAA: KEY EXECUTIVES
  • TABLE 185. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 186. MERCK KGAA: OPERATING SEGMENTS
  • TABLE 187. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 188. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 189. AVANTOR, INC.: KEY EXECUTIVES
  • TABLE 190. AVANTOR, INC.: COMPANY SNAPSHOT
  • TABLE 191. AVANTOR, INC.: OPERATING SEGMENTS
  • TABLE 192. AVANTOR, INC.: PRODUCT PORTFOLIO
  • TABLE 193. AVANTOR, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOPRESERVATION MARKET SEGMENTATION
  • FIGURE 2. GLOBAL BIOPRESERVATION MARKET
  • FIGURE 3. SEGMENTATION BIOPRESERVATION MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN BIOPRESERVATION MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALBIOPRESERVATION MARKET
  • FIGURE 11. BIOPRESERVATION MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. BIOPRESERVATION MARKET FOR BIOPRESERVATION MEDIA, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. BIOPRESERVATION MARKET FOR BIOSPECIMEN EQUIPMENT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. BIOPRESERVATION MARKET FOR FREEZERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. BIOPRESERVATION MARKET FOR CRYOGENIC STORAGE SYSTEMS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. BIOPRESERVATION MARKET FOR THAWING EQUIPMENT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. BIOPRESERVATION MARKET FOR REFRIGERATORS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. BIOPRESERVATION MARKET SEGMENTATION, BY BY BIOSPECIMEN
  • FIGURE 19. BIOPRESERVATION MARKET FOR STEM CELLS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. BIOPRESERVATION MARKET FOR ORGANS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. BIOPRESERVATION MARKET FOR HUMAN TISSUE SAMPLES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. BIOPRESERVATION MARKET FOR OTHER BIOSPECIMENS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. BIOPRESERVATION MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 24. BIOPRESERVATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. BIOPRESERVATION MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. BIOPRESERVATION MARKET FOR CLINICAL TRIALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 27. BIOPRESERVATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 28. BIOPRESERVATION MARKET SEGMENTATION, BY BY END USER
  • FIGURE 29. BIOPRESERVATION MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 30. BIOPRESERVATION MARKET FOR GENE BANKS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 31. BIOPRESERVATION MARKET FOR BIOBANKS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 32. BIOPRESERVATION MARKET FOR OTHER END USERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 33. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 34. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 35. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 36. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 37. COMPETITIVE DASHBOARD
  • FIGURE 38. COMPETITIVE HEATMAP: BIOPRESERVATION MARKET
  • FIGURE 39. TOP PLAYER POSITIONING, 2024
  • FIGURE 40. SIGMA-ALDRICH CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. SIGMA-ALDRICH CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. SIGMA-ALDRICH CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. THERMO FISHER SCIENTIFIC INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. BIOLIFE SOLUTIONS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. BIOLIFE SOLUTIONS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. BIOLIFE SOLUTIONS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. CESCA THERAPEUTICS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. CESCA THERAPEUTICS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. CESCA THERAPEUTICS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. VWR CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. VWR CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. VWR CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. CUSTOM BIOGENIC SYSTEMS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. CUSTOM BIOGENIC SYSTEMS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. CUSTOM BIOGENIC SYSTEMS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 58. CORE DYNAMICS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 59. CORE DYNAMICS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 60. CORE DYNAMICS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 61. PRINCETON CRYOTECH: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 62. PRINCETON CRYOTECH: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 63. PRINCETON CRYOTECH: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 64. MERCK KGAA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 65. MERCK KGAA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 66. MERCK KGAA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 67. AVANTOR, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 68. AVANTOR, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 69. AVANTOR, INC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Biopreservation Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue